Estrogen receptor status is the most important prognostic factor in breast cancer with ten or more positive lymph nodes |
| |
Authors: | Y Ogawa Tetsuro Ishikawa Bunzo Nakata Katsumi Ikeda Yasutake Uchima Yasuyuki Kato Kazuhiko Yoshikawa Michio Sowa Kosei Hirakawa |
| |
Institution: | (1) First Department of Surgery, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan Tel. +81-6-6645-3838; Fax +81-6-6646-6450, JP;(2) Institute of Geriatrics and Medical Science, Osaka City University Medical School, Osaka, Japan, JP;(3) Department of Surgery, Sumitomo Hospital, Osaka, Japan, JP;(4) Osaka City General Hospital, Osaka, Japan, JP |
| |
Abstract: | Background. In breast cancer, the prognosis worsens with increasing lymph node involvement, and aggressive therapies may prolong survival
in patients with advanced breast cancer. However, there are sub-populations of patients with advanced breast cancer with ten
or more diseased nodes who have long survival. Implementing appropriate treatment depends on having a realistic and well-founded
view of the prognosis.
Methods. Sixty-nine patients (mean follow-up, 46 months) were enrolled. All patients underwent adjuvant therapy following radical
mastectomy. Thirty-seven patients relapsed after curative surgery and 40 died of their cancer. Clinicopathologic factors,
tumor estrogen receptor (ER) status, progesterone receptor status, and p53 protein expression were analyzed for prognostic
significance.
Results. Lower lymph node stage and positive ER status reflected longer relapse-free survival (P = 0.001 and P = 0.0001, respectively). Lower tumor stage (P = 0.039), lower lymph node stage (P = 0.006), absence of distant metastasis (P = 0.006), positive ER status (P = 0.0002), and negative p53 status (P = 0.02) reflected longer overall survival. ER status was the only independent significant prognostic factor for both relapse-free
and overall survival.
Conclusion. ER status, an indicator of response to endocrine therapy, was the most significant factor predicting prognosis in patients
with breast cancer with ten or more positive lymph nodes.
Received: February 25, 1998 / Accepted: December 24, 1998 |
| |
Keywords: | Breast cancer Estrogen receptor Prognostic factors |
本文献已被 SpringerLink 等数据库收录! |
|